Melanoma vaccine plus immunotherapy cuts death/recurrence risk in large trial

A large study shows a melanoma vaccine combined with immunotherapy significantly reduces the risk of death or recurrence. The effect is confirmed but the magnitude and long-term durability remain to be fully assessed. This could shift standard of care for melanoma and boost the cancer vaccine field.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works